C. R. M. Hay, Trevor Baglin, P. Collins, F. G. H. Hill, David Keeling,
... et al, 1994; Kreuz et al, 1995; Mauser-Bunschoten et al, 1995; Brackmann, 1996; DiMichele et al, ... to achieve tolerance (Kreuz et al, 1995; Mauser-Bunschoten et al, 1995). A low peak historical inhibitor ... et al, 1994; Kreuz et al, 1995; Mauser-Bunschoten et al, 1995; DiMichele et al, 1999). Although ... Kreuz et al, 1995), but not others (Mauser-Bunschoten et al, 1995; DiMichele et al, 1999, 2001). ... 10 BU/ml have been notably successful (Mauser-Bunschoten et al, 1995; Smith et al, 1999; Rocino ... initiation of ITI (Kreutz et al, 1995; Mauser-Bunschoten et al, 1995; Brackmann, 1996; Lenk, 1999). Tolerance ...
Tópico(s): Blood Coagulation and Thrombosis Mechanisms
2000 - Wiley | British Journal of Haematology
Peter W. Collins, Elizabeth Chalmers, Daniel P. Hart, Ri Liesner, Savita Rangarajan, Kate Talks, Mike Williams, C. R. M. Hay,
... et al (2009), Eckhardt et al (2011), Mauser-Bunschoten et al (2012) FVIII/FIX mutation analysis should ... 2011) Kroner (1999), Brackmann et al (1996) Mauser-Bunschoten et al (1995) Kreuz et al (1995), DiMichele ( ... to be influenced by the product-type (Mauser-Bunschoten et al, 1995; Brackmann et al, 1996; Batlle ... BU/ml show very high success-rates (Mauser-Bunschoten et al, 1995; Rocino & de Biasi, 1999; Smith ... good risk patients (Mariani et al, 1994; Mauser-Bunschoten et al, 1995; DiMichele & Kroner, 2002; Hay & DiMichele, ...
Tópico(s): Hemostasis and retained surgical items
2012 - Wiley | British Journal of Haematology
Karin van Dijk, Johanna G. van der Bom, Kathelijn Fischer, Philip G. de Groot, H. Marijke van den Berg,
... 5Fischer K. Van Der Bom J.G. Mauser‐Bunschoten E.P. Roosendaal G. Prejs R. Grobbee D. ... Lenting P.J. De Groot P.G. Mauser‐Bunschoten E.P. Roosendaal G. Grobbee D.E. Van ... Van Der Bom J.G. Prejs R. Mauser‐Bunschoten E.P. Roosendaal G. Grobbee D.E. Van ... Van Der Bom J.G. Prejs R. Mauser‐Bunschoten E.P. Roosendaal G. Grobbee D.E. Van ... Van Der Bom J.G. Prejs R. Mauser‐Bunschoten E.P. Roosendaal G. Grobbee D.E. Van ...
Tópico(s): Blood Coagulation and Thrombosis Mechanisms
2007 - Elsevier BV | Journal of Thrombosis and Haemostasis
Evelien P. Mauser‐Bunschoten, G. Roosendaal, H. Marijke van den Berg,
... Therapy The Van Creveld Model E. P. Mauser-Bunschoten, Corresponding Author E. P. Mauser-Bunschoten Van Creveld Clinic, University Hospital Utrecht, Utrecht, The ... more papers by this author E. P. Mauser-Bunschoten, Corresponding Author E. P. Mauser-Bunschoten Van Creveld Clinic, University Hospital Utrecht, Utrecht, The ...
Tópico(s): Renal Transplantation Outcomes and Treatments
1996 - Wiley | Vox Sanguinis
Elisabeth M. Bik, Annelies E. Bunschoten, R.D. Gouw, Frits R. Mooi,
... for more papers by this author A.E. Bunschoten A.E. Bunschoten Molecular Microbiology Unit, National Institute of Public Health ... for more papers by this author A.E. Bunschoten A.E. Bunschoten Molecular Microbiology Unit, National Institute of Public Health ...
Tópico(s): Escherichia coli research studies
1995 - Springer Nature | The EMBO Journal
E. C. Goosenes, R. G. Bunschoten, V. Engelen, D. de Jong, J. H. M. van den Berg,
... NetherlandsSearch for more papers by this authorR. G. Bunschoten, R. G. Bunschoten DUPHAR B.V., Research Laboratories, Analytical Development Department, ... NetherlandsSearch for more papers by this authorR. G. Bunschoten, R. G. Bunschoten DUPHAR B.V., Research Laboratories, Analytical Development Department, ...
Tópico(s): Toxic Organic Pollutants Impact
1990 - Wiley | Journal of High Resolution Chromatography
F. G. C. M. UytdeHaag, H. Bunschoten, Kees Weijer, Albert D. M. E. Osterhaus,
... Netherlands.Search for more papers by this authorHans Bunschoten, Hans Bunschoten 1National Institute of Public Health and Environmental Hygiene, ... Netherlands.Search for more papers by this authorHans Bunschoten, Hans Bunschoten 1National Institute of Public Health and Environmental Hygiene, ...
Tópico(s): Antimicrobial Peptides and Activities
1986 - Wiley | Immunological Reviews
Idske C. L. Kremer Hovinga, Roger E. G. Schutgens, P. R. van der Valk, Lize F. D. van Vulpen, Eveline P. Mauser‐Bunschoten, Kathelijn Fischer,
... for more papers by this authorE. P. Mauser-Bunschoten, E. P. Mauser-Bunschoten Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, ... for more papers by this authorE. P. Mauser-Bunschoten, E. P. Mauser-Bunschoten Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, ...
Tópico(s): Coagulation, Bradykinin, Polyphosphates, and Angioedema
2018 - Wiley | Haemophilia
Karina Meijer, W. M. Smid, J. van der Meer,
... population. Blood 1993; 81: 412–18. 15 Mauser-Bunschoten EP, Bresters D & Van Drimmelen AAJ et al. ... 1995; 30: 367–71. 51 Bresters D, Mauser-Bunschoten EP & Cuypers HTM et al. Long term treatment ... patients. Gut 1993; Suppl.: S124–5. 52 Mauser-Bunschoten EP, Bresters D & Reesink HW et al. Effect ... J Rheumatol 1994; 21: 350–2. 63 Mauser-Bunschoten EP, Damen M & Reesink HW et al. Formation ...
Tópico(s): Hepatitis B Virus Studies
2000 - Wiley | Haemophilia
Manuel Carção, Louis M. Aledort,
... K, Van Der Bom JG, Roosendaal G, Mauser-Bunschoten EP. Effects of prophylactic treatment regimens in children ... 21 Fischer K, Van Der Bom JG, Mauser-Bunschoten EP et al. The effects of postponing prophylactic ... 26 Van Den Berg HM, Fischer K, Mauser-Bunschoten EP et al. Long-term outcome of individualized ...
Tópico(s): Coagulation, Bradykinin, Polyphosphates, and Angioedema
2007 - Wiley | Haemophilia
Anjali Sharathkumar, David Lillicrap, V. Blanchette, Melissa Kern, Jayne Leggo, A. M. Stain, L. Brooker, Manuel Carção,
... Bagnall R. Peake I.R. Berntorp E. Mauser Bunschoten E.P. Fijnvandraat K. Kasper C.K. White ... Bagnall R. Peake I.R. Berntorp E. Mauser Bunschoten E.P. Fijnvandraat K. Kasper C.K. White ... Bagnall R. Peake I.R. Berntorp E. Mauser Bunschoten E.P. Fijnvandraat K. Kasper C.K. White ...
Tópico(s): Cancer-related gene regulation
2003 - Elsevier BV | Journal of Thrombosis and Haemostasis
Alessandro Ghirardini, Maria Puopolo, Flavia Chiarotti, Guglielmo Mariani,
... Johnson, G. Mariani, L. Menza, E. P. Mauser-Bunschoten, R.T. Miller, M. Morfini, T. Nagao. Man ... Johnson, G. Mariani, L. Menza, E. P. Mauser-Bunschoten, R.T. Miller, M. Morfini, T. Nagao. Man ... 34: 378–384. 7 van Leewen EF, Mauser-Bunschoten EP, van Dijken PJ, Kok AJ, Sjamsedin-Visset ...
Tópico(s): Hepatitis B Virus Studies
1996 - Wiley | Vox Sanguinis
Peter Van den Bergh, Pieter A. van Doorn, Bart C. Jacobs, Luís Querol, Carina Bunschoten, David R. Cornblath,
... Barcelona, SpainSearch for more papers by this authorCarina Bunschoten MD, Department of Neurology and Immunology, Erasmus MC, ... Barcelona, SpainSearch for more papers by this authorCarina Bunschoten MD, Department of Neurology and Immunology, Erasmus MC, ...
Tópico(s): Peripheral Nerve Disorders
2020 - Wiley | Journal of the Peripheral Nervous System
E. Carlos Rodríguez‐Merchán, Evelien P. Mauser‐Bunschoten,
... for more papers by this authorE.P. Mauser-Bunschoten, E.P. Mauser-BunschotenSearch for more papers by ... for more papers by this authorE.P. Mauser-Bunschoten, E.P. Mauser-BunschotenSearch for more papers by ...
Tópico(s): Chronic Myeloid Leukemia Treatments
2004 - Wiley | Haemophilia
Ferdows Atiq, Karin Fijnvandraat, Karin P. M. van Galen, Britta A. P. Laros‐van Gorkom, Karina Meijer, Joke de Meris, Michiel Coppens, Eveline P. Mauser‐Bunschoten, Marjon H. Cnossen, Johanna G. van der Bom, Jeroen Eikenboom, Frank W.G. Leebeek,
... from CSL Behring and Bayer. E.P. Mauser-Bunschoten received unrestricted research/ educational support from CSL Behring, ...
Tópico(s): Antiplatelet Therapy and Cardiovascular Diseases
2019 - Wiley | American Journal of Hematology
Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen, Marjolein Peters, Eveline P. Mauser‐Bunschoten, R. Schwaab, Maria Gabriella Mazzucconi, Annarita Tagliaferri, Britta Siegmund, Sylvia Reitter-Pfoertner, Johanna G. van der Bom, Karin Fijnvandraat, Karin Fijnvandraat, Marjolein Peters, Pieter W. Kamphuisen, Pieter W. Kamphuisen, Johanna G. van der Bom, Kathelijne Peerlinck, Johannes Oldenburg, Elena Santagostino, Jan Astermark, Corien L. Eckhardt, Alice S. van Velzen, Nina Streefkerk, J.L. Loomans, A. van Eijkelenburg, Alexander Jansen, C.C. Kruijt, B. van Tienoven, Annieke C.G. van Baar, I.W. Corten, Karina Meijer, Marten R. Nijziel, Natasja Dors, Karly Hamulyák, Erik A.M. Beckers, Paul Brons, Britta A. P. Laros‐van Gorkom, Waander L. van Heerde, Frank W.G. Leebeek, Marieke J.H.A. Kruip, Marjon H. Cnossen, Eveline P. Mauser‐Bunschoten, Kathelijn Fischer, Frans J. Smiers, Cédric Hermans, R. Schwaab, Britta Siegmund, Robert Klamroth, C. Escuriola‐Ettingshausen, Christoph Königs, Pia Petrini, Mats Holmström, Anne Mäkipernaa, Christoph Male, Ingrid Pabinger, Sylvia Reitter-Pfoertner, Russell Keenan, Ri Liesner, Kate Khair, T. T. Yee, Dan Hart, Savita Rangarajan, Michael A. Mitchell, Garrett S. Thompson, Saturnino Haya, Andrés Moret, Ana Rosa Cid, Víctor Jiménez‐Yuste, Maria Elisa Mancuso, M.G. Mazzuconni, Cristina Santoro, Massimo Morfini, Giancarlo Castaman, Piercarla Schinco, Annarita Tagliaferri, G Rivolta, Helen Platokouki, Simon McRae,
The life expectancy of non-severe hemophilia A (HA) patients equals the life expectancy of the non-hemophilic population. However, data on the effect of inhibitor development on mortality and on hemophilia-related causes of death are scarce. The development of neutralizing factor VIII antibodies in non-severe HA patients may dramatically change their clinical outcome due to severe bleeding complications.We assessed the association between the occurrence of inhibitors and mortality in patients with ...
Tópico(s): Cancer-related gene regulation
2015 - Elsevier BV | Journal of Thrombosis and Haemostasis
... 4Lisman T. Mosnier L.O. Lambert T. Mauser-Bunschoten E.P. Meijers J.C.M. Nieuwenhuis H. ... 4Lisman T. Mosnier L.O. Lambert T. Mauser-Bunschoten E.P. Meijers J.C.M. Nieuwenhuis H. ...
Tópico(s): Hemophilia Treatment and Research
2003 - Elsevier BV | Journal of Thrombosis and Haemostasis
... 421–425. 15 Sjamsoedin LJ., Heijnen L., Mauser-Bunschoten EP., et al. The effect of activated prothrombin ... 150: 181–195. 33 Van Leeuwen EF., Mauser-Bunschoten EP., Van Kijken PJ., Kok AK., Sjamsoedin-Visser ...
Tópico(s): Hemostasis and retained surgical items
1995 - Wiley | Haemophilia
Evert M. van Schothorst, Annelies Bunschoten, Eline Verlinde, Patrick Schrauwen, Jaap Keijer,
... 6J mice, as shown recently (Van Schothorst EM, Bunschoten A, Schrauwen P, Mensink RP, Keijer J. FASEB ...
Tópico(s): Adipokines, Inflammation, and Metabolic Diseases
2011 - American Physical Society | Physiological Genomics
C. A. Lee, C. M. Kessler, Daryelle S. Varon, U. Martinowitz, M. Heim, Evelien P. Mauser‐Bunschoten, G. Roosendaal, H. Marijke van den Berg,
... for more papers by this authorE. P. MAUSER-BUNSCHOTEN, E. P. MAUSER-BUNSCHOTEN Van Creveldkliniek, University Hospital, Utrecht, the NetherlandsSearch for ... for more papers by this authorE. P. MAUSER-BUNSCHOTEN, E. P. MAUSER-BUNSCHOTEN Van Creveldkliniek, University Hospital, Utrecht, the NetherlandsSearch for ...
Tópico(s): Clinical practice guidelines implementation
1998 - Wiley | Haemophilia
Eveline P. Mauser‐Bunschoten, Dorine Bresters, H. W. Reesink,
... of Hepatitis C Virus to SpousesEveline P. Mauser-Bunschoten, Dorine Bresters, and Henk W. ReesinkEveline P. Mauser- ... 120:748-52. Google Scholar2. Bresters D, Mauser-Bunschoten EP, Reesink HW, Roosendaal G, van der Poel ... Author, Article, and Disclosure InformationAuthors: Eveline P. Mauser-Bunschoten; Dorine Bresters; Henk W. ReesinkAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails ...
Tópico(s): Hepatitis C virus research
1995 - American College of Physicians | Annals of Internal Medicine
Filip Eftimov, Carina Bunschoten, Yusuf A. Rajabally, Luís Querol, Max E. Adrichem, Jeffrey A. Allen, Jean-Cristophe Antoine, Ivana Basta, Peter Van den Bergh, Patricia H Blomkwist-Markens, Alexandra Breukel, Carina Bunschoten, David R. Cornblath, Kathrin Doppler, Filip Eftimov, Stephan Goedee, Robert D. M. Hadden, Thomas Harbo, Fu Liong Hiew, Bart C. Jacobs, Helmar C. Lehmann, Michael P. Lunn, Ingemar S. J. Merkies, Eduardo Nobile‐Orazio, Luís Querol, Yusuf A. Rajabally, Stephen Reddel, Jean‐Michel Vallat, Antonino Uncini,
Eight currently ongoing international CIDP registries were compared to assess infrastructure and collected clinical data, diagnostic data and biomaterials to enhance future research and improve standards of care in CIDP.
Tópico(s): Hereditary Neurological Disorders
2017 - Elsevier BV | Neuromuscular Disorders
Tjerk S.J. Opstal, Amber van Broekhoven, Aernoud T.L. Fiolet, Arend Mosterd, John W. Eikelboom, Stefan M. Nidorf, Peter L. Thompson, Charley A. Budgeon, Louis Bartels, Ron de Nooijer, Willem A. Bax, Jan G.P. Tijssen, Saloua El Messaoudi, Jan H. Cornel,
... Tim de Vries for medical review, and Petra Bunschoten and Wendy Tousain for site monitoring.Sources of ...
Tópico(s): interferon and immune responses
2022 - Lippincott Williams & Wilkins | Circulation
Johanna W. Bunschoten, Nafisa Husein, Orrin Devinsky, Jacqueline A. French, Josemir W. Sander, Roland D. Thijs, Mark R. Keezer,
Background and Objectives A recent Food and Drug Administration warning concerning an arrhythmogenic potential of lamotrigine created concern in the neurologic community. This warning was based on in vitro studies, but no clinically relevant risk was considered. This rapid systematic review aims to elucidate the risk of lamotrigine on sudden death or ECG abnormalities. Methods We conducted a systematic search of Ovid Medline and Ovid Embase, including randomized controlled trials and observational studies ...
Tópico(s): Pharmacological Effects and Toxicity Studies
2022 - Lippincott Williams & Wilkins | Neurology
Matthew E. Massett, Laura Monaghan, Shaun Patterson, Niamh Mannion, Roderick P. Bunschoten, Alex Hoose, Sandra Marmiroli, Robert M. J. Liskamp, Heather G. Jørgensen, David Vetrie, Alison M. Michie, Xu Huang,
Epigenomic dysregulation is a common pathological feature in human hematological malignancies. H3K9me3 emerges as an important epigenomic marker in acute myeloid leukemia (AML). Its associated methyltransferases, such as SETDB1, suppress AML leukemogenesis, whilst H3K9me3 demethylases KDM4C is required for mixed-lineage leukemia rearranged AML. However, the specific role and molecular mechanism of action of another member of the KDM4 family, KDM4A has not previously been clearly defined. In this ...
Tópico(s): Cancer-related gene regulation
2021 - Springer Nature | Cell Death and Disease
Marieke C. Punt, M.L. Waning, E. P. Mauser‐Bunschoten, Marieke J.H.A. Kruip, Jeroen Eikenboom, Laurens Nieuwenhuizen, Anja BU Mäkelburg, M.H.E. Driessens, Johannes J. Duvekot, Marjolein Peters, Jaap M. Middeldorp, Kitty W.M. Bloemenkamp, Roger E. G. Schutgens, A. Titia Lely, Karin P. M. van Galen,
Currently, there is no consensus on the optimal management to prevent postpartum hemorrhage (PPH) in hemophilia carriers. We aimed to evaluate peripartum management strategies in relation to maternal and neonatal bleeding outcomes by performing an extensive database search up to August 2020. Seventeen case-reports/series and 11 cohort studies were identified of overall 'poor' quality describing 502 deliveries. The PPH incidence in the individual patient data was 63%; 44% for those women receiving ...
Tópico(s): Myeloproliferative Neoplasms: Diagnosis and Treatment
2021 - Elsevier BV | Blood Reviews
Cas J. Isfordink, Karel J. van Erpecum, Marc van der Valk, Evelien P. Mauser‐Bunschoten, Michael Makris,
Summary The introduction of clotting factor concentrates has substantially improved the lives of people with clotting factor deficiencies. Unfortunately, the transmission of blood‐borne viral infections through these plasma‐derived products led to a huge epidemic of human immunodeficiency virus and viral hepatitis in people with haemophilia (PWH). In a significant proportion of PWH exposed to these viruses, the ensuing decades‐long chronic infection resulted in excess morbidity and mortality. Fortunately, ...
Tópico(s): Hemophilia Treatment and Research
2021 - Wiley | British Journal of Haematology
Joëlle J. E. Janssen, Bart Lagerwaard, Annelies Bunschoten, Huub F. J. Savelkoul, R. J. Joost van Neerven, Jaap Keijer, Vincent C. J. de Boer,
Abstract Analyzing metabolism of peripheral blood mononuclear cells (PBMCs) provides key opportunities to study the pathophysiology of several diseases, such as type 2 diabetes, obesity and cancer. Extracellular flux (XF) assays provide dynamic metabolic analysis of living cells that can capture ex vivo cellular metabolic responses to biological stressors. To obtain reliable data from PBMCs from individuals, novel methods are needed that allow for standardization and take into account the non-adherent ...
Tópico(s): Mitochondrial Function and Pathology
2021 - Nature Portfolio | Scientific Reports
Merel C. Broers, Carina Bunschoten, Judith Drenthen, Tiago A. O. Beck, Esther Brusse, Hester F. Lingsma, Jeffrey A. Allen, Richard A. Lewis, Pieter A. van Doorn, Bart C. Jacobs,
Abstract Background and purpose The aim of this study was to determine the frequency of over‐ and underdiagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) and to identify related diagnostic pitfalls. Methods We conducted a retrospective study in Dutch patients referred to the Erasmus University Medical Centre Rotterdam between 2011 and 2017 with either a diagnosis of CIDP or another diagnosis that was revised to CIDP. We used the European Federation of Neurological Societies/ ...
Tópico(s): Peripheral Nerve Disorders
2021 - Wiley | European Journal of Neurology
Shermarke Hassan, Erna C. van Balen, Cees Smit, Evelien P. Mauser‐Bunschoten, Lize F. D. van Vulpen, Jeroen Eikenboom, Erik A.M. Beckers, Louise Hooimeijer, Paula F. Ypma, Laurens Nieuwenhuizen, Michiel Coppens, Saskia E.M. Schols, Frank W.G. Leebeek, M.H.E. Driessens, Frits R. Rosendaal, Johanna G. van der Bom, Samantha C. Gouw,
We conducted six cross-sectional nationwide questionnaire studies among all patients with hemophilia in the Netherlands from 1972 until 2019 to assess how health outcomes have changed, with a special focus on patients >50 years of age.Data were collected on patient characteristics, treatment, (joint) bleeding, joint impairment, hospitalizations, human immunodeficiency virus and hepatitis C infections, and general health status (RAND-36).In 2019, 1009 patients participated, of whom 48% had mild, 15% ...
Tópico(s): Platelet Disorders and Treatments
2021 - Elsevier BV | Journal of Thrombosis and Haemostasis